1996
DOI: 10.1136/adc.75.4.355-b
|View full text |Cite
|
Sign up to set email alerts
|

Vasculitis associated with levamisole and circulating autoantibodies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
26
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(27 citation statements)
references
References 3 publications
1
26
0
Order By: Relevance
“…It is known to induce circulating autoantibodies (8). These effects on innate and adaptive immune responses may explain its propensity to induce autoimmunity and vasculitis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is known to induce circulating autoantibodies (8). These effects on innate and adaptive immune responses may explain its propensity to induce autoimmunity and vasculitis.…”
Section: Discussionmentioning
confidence: 99%
“…It was voluntarily withdrawn from the US market in 2000 due to its side-effect profile, which includes idiosyncratic agranulocytosis and the development of vasculitic lesions with prolonged exposure (7)(8)(9). Agranulocytosis was observed at rates of 2.5 to 13% in patients treated with moderate to high doses for protracted periods (10).…”
Section: Introductionmentioning
confidence: 99%
“…Reports exist describing cutaneous vasculitis (13,14) and the presence of autoantibodies, including ANCAs (15,16), in patients exposed to levamisole. Levamisole was withdrawn from the market in the United States in 2000 because of cases of treatment-associated agranulocytosis.…”
Section: Drugs Associated With Aavmentioning
confidence: 99%
“…Immunological abnormalities are a constant feature. Laboratory features such as perinuclear antineutrophil cytoplasmic in high titers [16,17] and lupus anticoagulant [5,14] appeared in our patient without positive specificities, although different antigen targets have been reported [17]. Rongoletti14 established the induction of such antibodies, as well as antiphospholipid antibodies in 4 patients who were negative before levamisol exposure.…”
Section: Discussionmentioning
confidence: 99%
“…Levamisol induced vasculitis was first reported simultaneously in 1978 in two women treated for rheumatoid arthritis [1,2]. Subsequent reports in children treated for nephrotic syndrome, and adults treated for multiple autoimmune conditions including vitiligo, appeared shortly after [3][4][5]. It was removed from the US market in 2000 because of the common occurrence of agranulocytosis6.…”
Section: Introductionmentioning
confidence: 99%